Full text is available at the source.
Abstract
The influence of baseline depressive-symptom severity on psychological outcomes during incretin receptor agonist therapy is not well understood.
- Baseline severity of depressive symptoms may affect psychological changes during GIP/GLP-1RA therapy.
- Short-term changes in binge-eating tendencies were evaluated alongside depressive symptoms.
- The relationship between depressive symptoms and psychological trajectories during therapy is unclear.
Simplified